Jury orders Bayer to pay $100 million over PCBs in Washington school
A Washington jury on Tuesday ordered Bayer to pay $100 million to four people who say they were sickened by toxic chemicals ...
Ex-SNL star Vanessa Bayer reveals why she lied to family about joining hit show: ‘You cannot tell a soul’
Comedian Vanessa Bayer heard “horror stories” about other cast members revealing they were cast on SNL before an official ...
Vanessa Bayer lied to family about joining “SNL” due to 'horror stories' of cast blabbing too early
For Vanessa Bayer, that includes keeping the news that she was cast on Saturday Night Live a secret.The former SNL star ...
“SNL” Alum Vanessa Bayer Recalls How Her Dad Used Her Childhood Leukemia as an Excuse and Would 'Drop the L Bomb'
The comedian shared how her family would use her diagnosis of lymphoblastic leukemia to get out of speeding tickets and get ...
Atletico Madrid vs Bayer Leverkusen predictions, odds and betting tips
Two Champions League dark horses go head-to-head on matchday seven of the league phase. Atletico Madrid vs Bayer Leverkusen ...
J.P. Morgan Sticks to Their Hold Rating for Bayer (0P6S)
In a report released today, Richard Vosser from J.P. Morgan maintained a Hold rating on Bayer (0P6S – Research Report), with a price target of ...
Champions League | Predicted Atlético Madrid v Bayer Leverkusen XIs – Xabi Alonso to make several changes
Xabi Alonso could make up to five changes to his Bayer Leverkusen side ahead of their Champions League against Atlético ...
Bayer says menopause drug succeeds in breast cancer study
The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...
devdiscourse15h
Dhanuka Agritech Expands Globally with Acquisition of Bayer AG's Fungicides
Dhanuka Agritech has acquired international rights for two fungicides from Bayer AG for Rs 165 crore. The acquisition includes rights to Bayer's Melody brand, its sub-brands for Iprovalicarb, and ...
FiercePharma6d
JPM25: Bayer gears up for 'must-win battles' as Xarelto's decline is in full swing, pharma chief says
These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...